FORTISNSEQ4 FY26May 22, 2026

Fortis Healthcare Limited

6,317words
4turns
0analyst exchanges
0executives
Key numbers — 40 extracted
INR 1
026 Fortis Healthcare announces Q4 FY26 and FY26 Financial Results Board recommends dividend of INR 1 per share (10% of Face Value) Q4 FY26 Results (vs Q4 FY25) ➢ Consolidated Revenues at INR 2,365
10%
thcare announces Q4 FY26 and FY26 Financial Results Board recommends dividend of INR 1 per share (10% of Face Value) Q4 FY26 Results (vs Q4 FY25) ➢ Consolidated Revenues at INR 2,365 Cr, up 17.8%
INR 2,365
of INR 1 per share (10% of Face Value) Q4 FY26 Results (vs Q4 FY25) ➢ Consolidated Revenues at INR 2,365 Cr, up 17.8% ➢ Operating EBITDA up 22.2%, margins at 22.5% vs 21.7% in Q4 FY25 ➢ Profit After Ta
17.8%
re (10% of Face Value) Q4 FY26 Results (vs Q4 FY25) ➢ Consolidated Revenues at INR 2,365 Cr, up 17.8% ➢ Operating EBITDA up 22.2%, margins at 22.5% vs 21.7% in Q4 FY25 ➢ Profit After Tax at INR 271
22.2%
26 Results (vs Q4 FY25) ➢ Consolidated Revenues at INR 2,365 Cr, up 17.8% ➢ Operating EBITDA up 22.2%, margins at 22.5% vs 21.7% in Q4 FY25 ➢ Profit After Tax at INR 271 Cr, up 44.2% FY26 Results (
22.5%
FY25) ➢ Consolidated Revenues at INR 2,365 Cr, up 17.8% ➢ Operating EBITDA up 22.2%, margins at 22.5% vs 21.7% in Q4 FY25 ➢ Profit After Tax at INR 271 Cr, up 44.2% FY26 Results (vs FY25) ➢ Conso
21.7%
Consolidated Revenues at INR 2,365 Cr, up 17.8% ➢ Operating EBITDA up 22.2%, margins at 22.5% vs 21.7% in Q4 FY25 ➢ Profit After Tax at INR 271 Cr, up 44.2% FY26 Results (vs FY25) ➢ Consolidated R
INR 271
p 17.8% ➢ Operating EBITDA up 22.2%, margins at 22.5% vs 21.7% in Q4 FY25 ➢ Profit After Tax at INR 271 Cr, up 44.2% FY26 Results (vs FY25) ➢ Consolidated Revenues at INR 9,128 Cr, up 17.3% ➢ Operat
44.2%
rating EBITDA up 22.2%, margins at 22.5% vs 21.7% in Q4 FY25 ➢ Profit After Tax at INR 271 Cr, up 44.2% FY26 Results (vs FY25) ➢ Consolidated Revenues at INR 9,128 Cr, up 17.3% ➢ Operating EBITDA u
INR 9,128
➢ Profit After Tax at INR 271 Cr, up 44.2% FY26 Results (vs FY25) ➢ Consolidated Revenues at INR 9,128 Cr, up 17.3% ➢ Operating EBITDA up 31.3%, margins at 22.8% vs 20.4% in FY25 ➢ Profit After Tax a
17.3%
Tax at INR 271 Cr, up 44.2% FY26 Results (vs FY25) ➢ Consolidated Revenues at INR 9,128 Cr, up 17.3% ➢ Operating EBITDA up 31.3%, margins at 22.8% vs 20.4% in FY25 ➢ Profit After Tax at INR 1,064
31.3%
FY26 Results (vs FY25) ➢ Consolidated Revenues at INR 9,128 Cr, up 17.3% ➢ Operating EBITDA up 31.3%, margins at 22.8% vs 20.4% in FY25 ➢ Profit After Tax at INR 1,064 Cr, up 31.5% Gurugram, May 2
Guidance — 20 items
For further details please contact
opening
By attending or assessing this presentation you acknowledge that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own analysis and be solely responsible for forming your own view of the potential future performance of the business of the Company.
For further details please contact
opening
Performance Highlights • Earnings and Financial Summary – Q4FY26 and FY26 2.
For further details please contact
opening
Appendix 4 Q4FY26 and FY26 PERFORMANCE HIGHLIGHTS 5 BUSINESS PERFORMANCE Consolidated (INR Cr) 6,298 1,101 (17.5%) 633 FY23 9.5 6,893 1,268 (18.4%) 645 FY24 12.9 7,783 1,588 (20.4%) 809 FY25 17.3 Revenue Op.
For further details please contact
opening
EBITDA Reported PAT Hospital Business (INR Cr) 5,107 862 (16.9%) FY23 5,686 1,058 (18.6%) FY24 11.3 6,528 1,339 (20.5%) 14.8 19.1 FY25 FY26 0 Revenue Op.
For further details please contact
opening
EBITDA 9,128 2,085 (22.8%) % Revenue Growth YoY 1,064 FY26 7,773 1,724 (22.2%) (XX%) Op.
For further details please contact
opening
EBITDA margin 2500 2000 1500 % Revenue Growth YoY FY23-26 CAGR 1000 Revenue Op.
For further details please contact
opening
Net Debt as on 31st Mar 2026 7 FY26 SNAPSHOT Consolidated Revenue Consolidated Op EBITDA Consolidated PBT1 9,128 Crores 17.3% 2,085 Crores (22.8% Margin) 31.3% 1,388 Crores 26.6% Consolidated PAT1 1,086 Crores 20.9% Net Debt / (Cash)3 Net Debt to EBITDA2,3 2,334 Crores 1.09x vs 0.93x Board recommends dividend of INR 1 per share (10% of face value); subject to shareholders’ approval 1.
For further details please contact
opening
Net Debt as on 31st Mar 2026 8 Key Updates – FY26 Acquisition of People Tree Hospital, Bengaluru Long-Term Lease for 200- Bedded Greater Noida Hospital Acquisition of Shrimann Hospital, Punjab Jan’26: Fortis acquired the 125-bedded People Tree Hospital in Yeshwanthpur, Bengaluru, for INR 430 Cr through a 100% acquisition of TMI Healthcare Pvt.
For further details please contact
opening
Q4FY25 Q3FY26 Q4FY26 Up 2.0% 15 FY26 HOSPITAL BUSINESS HIGHLIGHTS • Occupancy was at 68%, compared to 69% in FY25.
For further details please contact
opening
Occupied beds increased to 3,270 compared to 2,838 in FY25, a growth of 15.2%.
Speaking time
Cash
2
For further details please contact
1
Note
1
Opening remarks
For further details please contact
Anurag Kalra / Amit Mahendru Investor Relations +91-9810109253 / +91-9891094323 Fortis Healthcare Limited Ajey Maharaj Corporate Communication +91-9871798573 Fortis Healthcare Limited 3 FORTIS HEALTHCARE LIMITED EARNINGS PRESENTATION – Q4 FY26 and FY26 May 22, 2026 1 DISCLAIMER This presentation may not be copied, published, distributed or transmitted. The presentation has been prepared solely by the company. Any reference in this presentation to “Fortis Healthcare Limited” shall mean, collectively, the Company and its subsidiaries. This presentation has been prepared for informational purposes only. This presentation does not constitute a prospectus, offering circular or offering memorandum and is not an offer or invitation to buy or sell any securities, nor shall part, or all, of this presentation form the basis of, or be relied on in connection with, any contract or investment decision in relation to any securities. Furthermore, this presentation is not and should not be construed a
Cash
Domestic, 34.0% Pvt Corps, 1.0% Govt & PSUs, 8.7% CGHS, 4.5% ECHS, 7.4% International , 7.8% Pvt Corps, 1.2% Govt & PSUs, 8.7% International , 7.8% CGHS, 4.7% ECHS, 7.3% 24 HOSPITAL BUSINESS PERFORMANCE – Q4FY26 & FY26 Key healthcare facilities continue to witness a YoY and QoQ upward momentum in revenues Revenue Q4FY25 Q4FY26 286 262 217 203 172 181 163 140 146 152 157 135 154 125 107 95 75 60 70 53 All figures in INR Cr. FMRI Mohali Shalimar Bagh Noida BG Road FEHI Mulund Anandpur Faridabad Jaipur 1,137 991 902 812 723 633 Revenue FY25 FY26 642 540 571 605 590 492 577 501 All figures in INR Cr. 406 352 285 235 279 231 FMRI Mohali Shalimar Bagh Noida BG Road FEHI Mulund Anandpur Faridabad Jaipur 25 HOSPITAL BUSINESS PERFORMANCE – FY26 4.74 4.21 ARPOB (INR Cr per annum) FY25 FY26 3.41 3.12 2.42 2.60 3.02 3.01 3.45 3.18 2.96 2.38 2.20 2.35 1.67 1.80 1.63 1.46 1.71 1.64 FMRI Mohali Shalimar Bagh Noida BG Road FEHI Mulund Anandpur Faridabad Jaipur 81% 77% 73% 74% 78% 78% 82% 76% Occupancy
Note
FY26 witnessed YoY growth across key procedures: Cardiac Procedures grew by 13%, Ortho Procedures by 15%, Robotic Surgeries by 66%, Radiation Therapy by 19%, and Neuro and Spine Procedures by 13% 1Cardiac Procedures include Cardiac Surgery, Angiography, Angioplasty and other Cardiology procedures 2Transplants include Kidney, Liver and Bone Marrow Transplants 3Robotic Surgeries include Cardiac, Urology, Oncology, Gynae, Ortho and General Surgery 37 CLINICAL EXCELLENCE Q4 FY26 • Fortis Hospital, Gurugram, performed complex hybrid cardiac surgery, combining open bypass surgery with minimally invasive endovascular repair, on a 29-year-old suffering from a ruptured and massively dilated thoracic abdominal aorta, a condition associated with extremely high mortality • Fortis Escorts, Okhla Road, New Delhi, performed a balloon aortic valvotomy, a minimally invasive procedure to open the severely narrowed valve and restore blood flow, on a critically ill premature newborn delivered at 31 weeks
← All transcriptsFORTIS stock page →